Holocene Advisors, LP Mirati Therapeutics, Inc. Transaction History

Holocene Advisors, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $14.7 Million - $29.2 Million	-193,240 Reduced 18.56%	848,177 $69.7 Million
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $32.7 Million - $47.2 Million	248,024 Added 31.26%	1,041,417 $153 Million
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $9.27 Million - $12.5 Million	70,171 Added 9.7%	793,393 $140 Million
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $59.7 Million - $74.5 Million	414,251 Added 134.07%	723,222 $117 Million
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $4.4 Million - $6.14 Million	-27,689 Reduced 8.22%	308,971 $52.9 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $11.3 Million - $16.8 Million	69,978 Added 26.24%	336,660 $73.9 Million
Q3 2020 Nov 16, 2020	SELL	$113.26 - $167.27 $6.93 Million - $10.2 Million	-61,148 Reduced 18.65%	266,682 $44.3 Million
Q2 2020 Aug 14, 2020	SELL	$72.01 - $120.39 $5.53 Million - $9.25 Million	-76,849 Reduced 18.99%	327,830 $37.4 Million
Q1 2020 May 15, 2020	BUY	$69.78 - $116.21 $13.4 Million - $22.4 Million	192,748 Added 90.95%	404,679 $31.1 Million
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $7.44 Million - $13.6 Million	105,207 Added 98.58%	211,931 $27.3 Million
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $8.31 Million - $11.7 Million	106,724 New	106,724 $8.32 Million

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.